Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

Who Took Part

According to the abstract, 29 boys were involved.

PubMed indexes the participants as infants, young children and children, both men and women.

Prospective, randomized, controlled, single blind, interventional study conducted on 41 steroid-naïve pre-pubertal children (29 boys, 12 girls).

How the Study Was Run

The design is described as randomized and single-blind.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

Only one side, usually the boys, was kept unaware of whether Vitamin D, K2, Magnesium and Zinc was given.

Bone mineral content (BMC) and bone mineral density (BMD) at the lumbar spine (L1-L4) were estimated at baseline and at 12 weeks.

Mean percentage changes in BMC and BMD in IG and CG were compared.

What Was Measured

PubMed files the paper under topics including Absorptiometry, Photon, Adrenal Cortex Hormones, Bone Density, Bone Density Conservation Agents, Bone and Bones, Calcium, Dietary and Dietary Supplements.

What This Means in Plain Language

The paper is a randomized and single-blind study of Vitamin D, K2, Magnesium and Zinc in 29 boys.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2014 (Pediatric nephrology (Berlin, Germany)), a journal based in Germany.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.